IRF5−/− MRL/lpr mice had smaller spleens and lymph nodes, reduced titers of anti-nuclear and anti-dsDNA autoantibodies, lower levels of the complement-fixing IgG isotypes IgG2a, IgG2b and IgG3, less severe kidney disease and greatly improved survival. Here, IRF5 is linked to kidney disorder.